November 2019 Issue

GO TO FULL ISSUE

Get Enterprise-wide Access

MED UPDATES

Baqsimi
glucagon
A new nasal powder formulation for severe hypoglycemia

Gvoke
glucagon
A new subcutaneous injection formulation for severe hypoglycemia

Rybelsus
semaglutide
A new oral GLP-1 agonist for type 2 diabetes

MORE MED UPDATES